{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:07:55Z","timestamp":1795090075696,"version":"4.10.2"},"reference-count":127,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["81800497"],"award-info":[{"award-number":["81800497"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Inflammatory bowel disease (IBD), including Crohn\u2019s disease and ulcerative colitis, is characterized by chronic intestinal inflammation and impaired epithelial barrier function. Emerging evidence highlights the critical role of vascular remodeling and angiogenesis in IBD pathogenesis. This review explores the intricate relationship between blood vessels and the intestinal epithelial barrier, emphasizing how aberrant vascularization contributes to barrier dysfunction and disease progression. In IBD, excessive angiogenesis is driven by hypoxia, immune cell infiltration, and pro-inflammatory cytokines, further perpetuating inflammation and tissue damage. Key angiogenic factors, such as vascular endothelial growth factor (VEGF), angiopoietins, and platelet-derived growth factor (PDGF), are upregulated in IBD, promoting pathological vessel formation. These newly formed vessels are often immature and hyperpermeable, exacerbating leukocyte recruitment and inflammatory responses. Given the pivotal role of angiogenesis in IBD, anti-angiogenic therapies have emerged as a potential therapeutic strategy. Preclinical and clinical studies targeting VEGF and other angiogenic pathways have shown promise in reducing inflammation and promoting mucosal healing. This review summarizes current knowledge on vascular\u2013epithelial interactions in IBD, the mechanisms driving pathological angiogenesis, and the therapeutic potential of anti-angiogenic approaches, providing insights for future research and treatment development.<\/jats:p>","DOI":"10.3390\/biomedicines13051154","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T09:56:19Z","timestamp":1746784579000},"page":"1154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Angiogenic Factors and Inflammatory Bowel Diseases"],"prefix":"10.3390","volume":"13","author":[{"given":"Zhiru","family":"Li","sequence":"first","affiliation":[{"name":"Clinical Medical School, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-5199","authenticated-orcid":false,"given":"Qin","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"ref_1","first-page":"457","article-title":"Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn\u2019s and Colitis Epidemiology Study","volume":"153","author":"Ng","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.cgh.2022.06.030","article-title":"Global Hospitalization Trends for Crohn\u2019s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses","volume":"21","author":"Buie","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00384-024-04711-x","article-title":"Global, regional, and national burden of inflammatory bowel disease, 1990\u20132021: Insights from the global burden of disease 2021","volume":"39","author":"Lin","year":"2024","journal-title":"Int. J. Color. Dis."},{"key":"ref_5","first-page":"izae095","article-title":"Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study","volume":"26","author":"Visser","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ueg2.12319","article-title":"Environmental risk factors for inflammatory bowel disease","volume":"10","author":"Singh","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jarmakiewicz-Czaja, S., Zieli\u0144ska, M., Sokal, A., and Filip, R. (2022). Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update. Genes, 13.","DOI":"10.1155\/2022\/4344905"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"MaMentella, C., Scaldaferri, F., Pizzoferrato, M., Gasbarrini, A., and Miggiano, G.A.D. (2020). Nutrition, IBD and Gut Microbiota: A Review. Nutrients, 12.","DOI":"10.3390\/nu12040944"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.immuni.2023.01.002","article-title":"The landscape of immune dysregulation in Crohn\u2019s disease revealed through single-cell transcriptomic profiling in the ileum and colon","volume":"56","author":"Kong","year":"2023","journal-title":"Immunity"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s40001-024-02224-5","article-title":"Angiogenesis, a key point in the association of gut microbiota and its metabolites with disease","volume":"29","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.32604\/biocell.2023.043422","article-title":"Bioinformatic analysis and in vivo validation of angiogenesis related genes in inflammatory bowel disease","volume":"47","author":"Dong","year":"2023","journal-title":"Biocell"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Xie, Y., Ma, Y., Xu, L., Liu, H., Ge, W., Wu, B., Duan, H., Zhang, H., Fu, Y., and Xu, H. (2024). Inhibition of Angiogenesis and Effect on Inflammatory Bowel Disease of Ginsenoside Rg3-Loaded Thermosensitive Hydrogel. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16101243"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Britzen-Laurent, N., Weidinger, C., and Sturzl, M. (2023). Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065517"},{"key":"ref_14","first-page":"970890","article-title":"Angiogenesis in Inflammatory Bowel Disease","volume":"2015","author":"Alkim","year":"2015","journal-title":"Int. J. Inflamm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1038\/ctg.2016.54","article-title":"Human Intestinal Barrier Function in Health and Disease","volume":"7","author":"Wells","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nakai, D., and Miyake, M. (2023). Intestinal Membrane Function in Inflammatory Bowel Disease. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16010029"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jevs.2017.02.009","article-title":"Alterations in Intestinal Permeability: The Role of the \u201cLeaky Gut\u201d in Health and Disease","volume":"52","author":"Stewart","year":"2017","journal-title":"J. Equine Vet. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hu, J.C.E., Wei\u00df, F., Bojarski, C., Branchi, F., Schulzke, J.D., Fromm, M., and Krug, S.M. (2021). Expression of tricellular tight junction proteins and the paracellular macromolecule barrier are recovered in remission of ulcerative colitis. BMC Gastroenterol., 21.","DOI":"10.1186\/s12876-021-01723-7"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1368-5031.2004.0103.x","article-title":"The role of the endothelium in the control of vascular function","volume":"58","author":"Hurairah","year":"2004","journal-title":"Int. J. Clin. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCRESAHA.119.315743","article-title":"Bone Marrow-Derived Cells Restore Functional Integrity of the Gut Epithelial and Vascular Barriers in a Model of Diabetes and ACE2 Deficiency","volume":"125","author":"Duan","year":"2019","journal-title":"Circ. Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Dicks, L.M.T., Dreyer, L., Smith, C., and van Staden, A.D. (2018). A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut-Blood Barrier?. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.02938"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1242\/jcs.023887","article-title":"Tight junctions at a glance","volume":"121","author":"Balda","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.4049\/jimmunol.171.11.6164","article-title":"Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms","volume":"171","author":"Bruewer","year":"2003","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm0996-998","article-title":"Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-\u03baB abrogates established experimental colitis in mice","volume":"2","author":"Neurath","year":"1996","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth","volume":"491","author":"Grivennikov","year":"2012","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zheng, D., Liu, J., Piao, H., Zhu, Z., Wei, R., and Liu, K. (2022). ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1039241"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Haque, M., Kaminsky, L., Abdulqadir, R., Engers, J., Kovtunov, E., Rawat, M., Al-Sadi, R., and Ma, T.Y. (2024). Lactobacillus acidophilus inhibits the TNF-\u03b1-induced increase in intestinal epithelial tight junction permeability via a TLR-2 and PI3K-dependent inhibition of NF-\u03baB activation. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1348010"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","article-title":"The intestinal barrier: A fundamental role in health and disease","volume":"11","author":"Vancamelbeke","year":"2017","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ayansola, H., Mayorga, E.J., and Jin, Y. (2024). Subepithelial Stromal Cells: Their Roles and Interactions with Intestinal Epithelial Cells during Gut Mucosal Homeostasis and Regeneration. Biomedicines, 12.","DOI":"10.20944\/preprints202402.0346.v1"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1038\/emm.2017.20","article-title":"Roles of intestinal epithelial cells in the maintenance of gut homeostasis","volume":"49","author":"Okumura","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"R1135","DOI":"10.1016\/j.cub.2023.09.027","article-title":"Tight junctions","volume":"33","author":"Balda","year":"2023","journal-title":"Curr. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00281-024-01026-5","article-title":"The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation","volume":"47","author":"Okumura","year":"2024","journal-title":"Semin. Immunopathol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Barbara, G., Barbaro, M.R., Fuschi, D., Palombo, M., Falangone, F., Cremon, C., Marasco, G., and Stanghellini, V. (2021). Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.790387"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: Regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.aad0135","article-title":"A gut-vascular barrier controls the systemic dissemination of bacteria","volume":"350","author":"Spadoni","year":"2015","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kumar, K.P., Ooi, J.D., and Goldberg, R. (2023). The interplay between the microbiota, diet and T regulatory cells in the preservation of the gut barrier in inflammatory bowel disease. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1291724"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/092986711794839179","article-title":"Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions","volume":"18","author":"Catalioto","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","article-title":"The intestinal epithelial barrier: A therapeutic target?","volume":"14","author":"Odenwald","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_39","first-page":"566","article-title":"Advances in medical therapy of inflammatory bowel disease","volume":"5","author":"Panaccione","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.7150\/ijbs.65476","article-title":"Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt\/\u03b2-catenin pathway","volume":"18","author":"Dong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"106610","DOI":"10.1016\/j.intimp.2020.106610","article-title":"PIK3R3 regulates ZO-1 expression through the NF-kB pathway in inflammatorybowel disease","volume":"85","author":"Ibrahim","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jare.2023.04.011","article-title":"The miR-7\/EGFR axis controls the epithelial cell immunomodulation and regeneration and orchestrates the pathology in inflammatory bowel disease","volume":"57","author":"Zhao","year":"2024","journal-title":"J. Adv. Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Di Tommaso, N., Gasbarrini, A., and Ponziani, F.R. (2021). Intestinal Barrier in Human Health and Disease. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182312836"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/ecco-jcc\/jjad064","article-title":"Transepithelial Barrier Dysfunction Drives Microbiota Dysbiosis to Initiate Epithelial Clock-driven Inflammation","volume":"17","author":"Pai","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Zhang, J., Cen, L., Zhang, X., Tang, C., Chen, Y., Zhang, Y., Yu, M., Lu, C., Li, M., and Li, S. (2022). MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT. Redox Biol., 56.","DOI":"10.1016\/j.redox.2022.102469"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mahapatro, M., Erkert, L., and Becker, C. (2021). Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut. Cells, 10.","DOI":"10.3390\/cells10010111"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1053\/j.gastro.2006.03.054","article-title":"Angiogenesis as a novel component of inflammatory bowel disease pathogenesis","volume":"130","author":"Danese","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e14361","DOI":"10.1111\/eci.14361","article-title":"Vascular endothelial growth factor in inflammatory bowel disease: A systematic review and meta-analysis","volume":"55","author":"Zoroddu","year":"2025","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1590\/1516-3180.2018.0274161118","article-title":"Vascular endothelial growth factor, endostatin levels and clinical features among patients with ulcerative colitis and irritable bowel syndrome and among healthy controls: A cross-sectional analytical study","volume":"136","author":"Aksoy","year":"2018","journal-title":"Sao Paulo Med. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2362.2007.01914.x","article-title":"Angiogenesis in inflammatory bowel disease","volume":"38","author":"Pousa","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.clinbiochem.2009.08.002","article-title":"Platelet-derived growth factor-BB reflects clinical, inflammatory and angiogenic disease activity and oxidative stress in inflammatory bowel disease","volume":"42","author":"Neubauer","year":"2009","journal-title":"Clin. Biochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jgh.12748","article-title":"Confocal laser endomicroscopy: A new gold standard for the assessment of mucosal healing in ulcerative colitis","volume":"30","author":"Ahluwalia","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ecco-jcc\/jjw076","article-title":"Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis","volume":"10","author":"Ippolito","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MOG.0b013e32810c8de3","article-title":"Inflammation and the mucosal microcirculation in inflammatory bowel disease: The ebb and flow","volume":"23","author":"Danese","year":"2007","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.gastro.2008.12.029","article-title":"Is inflammatory bowel disease a vascular disease? Targeting angiogenesis improves chronic inflammation in inflammatory bowel disease","volume":"136","author":"Binion","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jcp.56.3.209","article-title":"Hypoxia inducible factor 1\u03b1 and 2\u03b1 overexpression in inflammatory bowel disease","volume":"56","author":"Giatromanolaki","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ar.21110","article-title":"Inflammation-induced intussusceptive angiogenesis in murine colitis","volume":"293","author":"Konerding","year":"2010","journal-title":"Anat. Rec."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00441-003-0784-3","article-title":"Vascular remodeling by intussusceptive angiogenesis","volume":"314","author":"Djonov","year":"2003","journal-title":"Cell Tissue Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e45054","DOI":"10.15252\/embr.201745054","article-title":"EphrinB2\/EphB4 signaling regulates non-sprouting angiogenesis by VEGF","volume":"19","author":"Groppa","year":"2018","journal-title":"EMBO Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mvr.2013.02.002","article-title":"Intussusceptive remodeling of vascular branch angles in chemically-induced murine colitis","volume":"87","author":"Ackermann","year":"2013","journal-title":"Microvasc. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e10862","DOI":"10.15252\/emmm.201910862","article-title":"Endothelial MT1-MMP targeting limits intussusceptive angiogenesis and colitis via TSP1\/nitric oxide axis","volume":"12","author":"Esteban","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.2174\/138161206777947461","article-title":"Cytokines and chemokines as regulators of angiogenesis in health and disease","volume":"12","author":"Benelli","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"ref_63","first-page":"323","article-title":"Advances in the management of inflammatory bowel diseases","volume":"77","author":"Reenaers","year":"2022","journal-title":"Rev. Med. Liege"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2353\/ajpath.2008.070593","article-title":"Multiple pathogenic role of microvasculature in inflammatory bowel disease: A Jack of all trades","volume":"172","author":"Deban","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2023","journal-title":"Nat. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/j.gastro.2008.09.064","article-title":"VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis","volume":"136","author":"Scaldaferri","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.3402\/ljm.v7i0.8942","article-title":"Thrombospondin-1 and VEGF in inflammatory bowel disease","volume":"7","author":"Alkim","year":"2012","journal-title":"Libyan J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1038\/s41467-022-30063-7","article-title":"Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy","volume":"13","author":"Huijbers","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.dld.2008.02.010","article-title":"Increased expression of VEGF and CD146 in patients with inflammatory bowel disease","volume":"40","author":"Tsiolakidou","year":"2008","journal-title":"Dig. Liver Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.lfs.2010.10.026","article-title":"Role of anti-angiogenic factor endostatin in the pathogenesis of experimental ulcerative colitis","volume":"88","author":"Tolstanova","year":"2011","journal-title":"Life Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1172\/JCI72189","article-title":"VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease","volume":"124","author":"Correale","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Wang, X.L., Zhao, J., Qin, L., and Qiao, M. (2016). Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis. Braz. J. Med. Biol. Res., 49.","DOI":"10.1590\/1414-431x20154738"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000492851","article-title":"Exosomes from Adipose-Derived Stem Cells Promotes VEGF-C-Dependent Lymphangiogenesis by Regulating miRNA-132\/TGF-\u03b2 Pathway","volume":"49","author":"Wang","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.mpmed.2015.02.006","article-title":"Crohn\u2019s disease","volume":"43","author":"Harit","year":"2015","journal-title":"Medicine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Hendrickson, B.A., Gokhale, R., and Cho, J.H. (2002). Clinical aspects and pathophysiology of inflammatory bowel disease. Clin. Microbiol. Rev., 15.","DOI":"10.1128\/CMR.15.1.79-94.2002"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/HP.S219049","article-title":"Markers of Hypoxia Correlate with Histologic and Endoscopic Severity of Colitis in Inflammatory Bowel Disease","volume":"8","author":"Battista","year":"2020","journal-title":"Hypoxia"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s10620-015-3698-5","article-title":"Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease","volume":"60","author":"Tolstanova","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/09513590.2017.1318375","article-title":"Placental growth factor (PlGF) as an angiogenic\/inflammatory switcher: Lesson from early pregnancy losses","volume":"33","author":"Nejabati","year":"2017","journal-title":"Gynecol. Endocrinol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbrc.2016.01.073","article-title":"Placental growth factor enhances angiogenesis in human intestinal microvascular endothelial cells via PI3K\/Akt pathway: Potential implications of inflammation bowel disease","volume":"470","author":"Zhou","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Thapa, K., Khan, H., Kaur, G., Kumar, P., and Singh, T.G. (2023). Therapeutic targeting of angiopoietins in tumor angiogenesis and cancer development. Biochem. Biophys. Res. Commun., 687.","DOI":"10.1016\/j.bbrc.2023.149130"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ibd.21410","article-title":"Angiogenin, angiopoietin-1, angiopoietin-2 and endostatin serum levels in inflammatory bowel disease","volume":"7","author":"Oikonomou","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/ibd.21150","article-title":"Angiopoietin-2 in experimental colitis","volume":"16","author":"Ganta","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10753-020-01378-8","article-title":"Thalidomide Inhibits Angiogenesis via Downregulation of VEGF and Angiopoietin-2 in Crohn\u2019s Disease","volume":"44","author":"Wang","year":"2021","journal-title":"Inflammation"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Fang, Z., Qu, S., Ji, X., Zheng, C., Mo, J., Xu, J., Zhang, J., and Shen, H. (2024). Correlation between PDGF-BB and M1-type macrophage in inflammatory bowel disease: A case-control study. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03518-y"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Kataria, J., Kerr, J., Lourenssen, S.R., and Blennerhassett, M.G. (2022). Nintedanib regulates intestinal smooth muscle hyperplasia and phenotype in vitro and in TNBS colitis in vivo. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-14491-5"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e17208","DOI":"10.1097\/MD.0000000000017208","article-title":"Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease","volume":"98","year":"2019","journal-title":"Medicine"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Rioux, J.D., Boucher, G., Forest, A., Bouchard, B., Coderre, L., Daneault, C., Frayne, I.R., Legault, J.T., Consortium, I., and Bitton, A. (2024). A pilot study to identify blood-based markers associated with response to treatment with Vedolizumab in patients with Inflammatory Bowel Disease. medRxiv.","DOI":"10.1101\/2024.09.19.24314034"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00054725-200409000-00011","article-title":"Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn\u2019s disease","volume":"10","author":"Ciccocioppo","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1023\/A:1018882322566","article-title":"Serum basic fibroblast growth factor in pediatric Crohn\u2019s disease. Implications for wound healing","volume":"42","author":"Bousvaros","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2009.03424.x","article-title":"Molecular control of blood flow and angiogenesis: Role of nitric oxide","volume":"7","author":"Sessa","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Aguilar, G., Koning, T., Ehrenfeld, P., and S\u00e1nchez, F.A. (2020). Role of NO and S-nitrosylation in the Expression of Endothelial Adhesion Proteins That Regulate Leukocyte and Tumor Cell Adhesion. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.595526"},{"key":"ref_93","first-page":"881","article-title":"Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Radic","volume":"29","author":"Binion","year":"2000","journal-title":"Biol. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"G1323","DOI":"10.1152\/ajpgi.00499.2006","article-title":"Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease","volume":"292","author":"Horowitz","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0016-5085(03)00699-1","article-title":"Acquired microvascular dysfunction in inflammatory bowel disease:Loss of nitric oxide-mediated vasodilation","volume":"125","author":"Hatoum","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/ibd\/izac017","article-title":"Influence and Implications of the Molecular Paradigm of Nitric Oxide Underlying Inflammatory Reactions of the Gastrointestinal Tract of Dog: A Major Hallmark of Inflammatory Bowel Disease","volume":"28","author":"Rana","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.molcel.2010.07.013","article-title":"S-nitrosylation of \u03b2-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability","volume":"39","author":"Thibeault","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_98","first-page":"5541","article-title":"eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases","volume":"126","author":"Lin","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Zhao, J., Liu, Z., and Chang, Z. (2021). Lipopolysaccharide induces vascular endothelial cell pyroptosis via the SP1\/RCN2\/ROS signaling pathway. Eur. J. Cell Biol., 100.","DOI":"10.1016\/j.ejcb.2021.151164"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"G137","DOI":"10.1152\/ajpgi.00309.2003","article-title":"Paradoxical roles of different nitric oxide synthase isoforms in colonic injury","volume":"286","author":"Beck","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_101","first-page":"153","article-title":"Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic","volume":"31","author":"Hokari","year":"2001","journal-title":"Biol. Med."},{"key":"ref_102","first-page":"1679","article-title":"Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radic","volume":"35","author":"Sasaki","year":"2003","journal-title":"Biol. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"G865","DOI":"10.1152\/ajpgi.00187.2004","article-title":"Relative contributions of NOS isoforms during experimental colitis: Endothelial-derived NOS maintains mucosal integrity","volume":"287","author":"Vallance","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1389203716666150224150756","article-title":"Angiogenesis-related proteins\u2014Their role in the pathogenesis and treatment of inflammatory bowel disease","volume":"16","author":"Eder","year":"2015","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12967-024-05058-1","article-title":"Predictive biomarkers for anti-TNF \u03b1 therapy in IBD patients","volume":"22","author":"Kumar","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1582-4934.2010.01033.x","article-title":"Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature","volume":"15","author":"Rutella","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/039463201102400206","article-title":"Anti-TNF-\u03b1 antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells","volume":"24","author":"Altorjay","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ajg.2011.48","article-title":"Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn\u2019s disease","volume":"106","author":"Rutella","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2456179","DOI":"10.1155\/2016\/2456179","article-title":"Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases","volume":"2016","author":"Jakubowska","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Pehrsson, M., Domislovic, V., Alexdottir, M.S., Brinar, M., Karsdal, M.A., Barisic, A., Krznaric, Z., and Mortensen, J.H. (2023). Blood-Based Biomarkers Reflecting Protease 3 and MMP-12 Catalyzed Elastin Degradation as Potential Noninvasive Surrogate Markers of Endoscopic and Clinical Disease in Inflammatory Bowel Disease. J. Clin. Med., 13.","DOI":"10.3390\/jcm13010021"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Herrera-G\u00f3mez, R.G., Grecea, M., Gallois, C., Boige, V., Pautier, P., Pistilli, B., Planchard, D., Malka, D., Ducreux, M., and Mir, O. (2022). Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease. Cancers, 14.","DOI":"10.3390\/cancers14122914"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/gutjnl-2020-321702","article-title":"Immunotherapy for advanced hepatocellular carcinoma: A focus on special subgroups","volume":"70","author":"Pinter","year":"2021","journal-title":"Gut"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/ibd.21545","article-title":"Feasibility of anti-VEGF agent bevacizumab in patients with Crohn\u2019s disease","volume":"17","author":"Coriat","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_114","first-page":"e39538","article-title":"Complete Remission of Advanced Hepatocellular Carcinoma in a Patient With Ulcerative Colitis Treated With Atezolizumab and Bevacizumab: A Case Report","volume":"15","author":"Pentapati","year":"2023","journal-title":"Cureus"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(24)00063-1","article-title":"Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-Week results from a randomised, double-masked, non-inferiority, phase 3 trial","volume":"403","author":"Lanzetta","year":"2024","journal-title":"Lancet"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/17425255.2022.2160316","article-title":"Pharmacokinetics and pharmacodynamics of approved monoclonal antibody therapy for colorectal cancer","volume":"18","author":"Ros","year":"2022","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.21873\/invivo.13696","article-title":"Protective Effects of Imatinib on a DSS-induced Colitis Model Through Regulation of Apoptosis and Inflammation","volume":"38","author":"Kim","year":"2024","journal-title":"In Vivo"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s10147-023-02325-x","article-title":"Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST","volume":"28","author":"Teranishi","year":"2023","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1053\/j.gastro.2023.08.038","article-title":"Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study","volume":"165","author":"Allegretti","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10409238.2016.1199535","article-title":"The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases","volume":"51","author":"Vandooren","year":"2016","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s10753-019-01085-z","article-title":"Paeoniflorin Prevents Intestinal Barrier Disruption and Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in Caco-2 Cell Monolayers","volume":"42","author":"Wu","year":"2019","journal-title":"Inflammation"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Chu, C., Wang, X., Yang, C., Chen, F., Shi, L., Xu, W., Wang, K., Liu, B., Wang, C., and Sun, D. (2023). Neutrophil extracellular traps drive intestinal microvascular endothelialferroptosis by impairing Fundc1-dependent mitophagy. Redox Biol., 67.","DOI":"10.1016\/j.redox.2023.102906"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"G5","DOI":"10.1152\/ajpgi.00107.2007","article-title":"Pathogenic angiogenesis in IBD and experimental colitis: New ideas and therapeutic avenues","volume":"293","author":"Chidlow","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/ibd\/izad255","article-title":"The Crohn\u2019s Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions","volume":"30","author":"Westoby","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(21)00377-0","article-title":"Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: A systematic review and network meta-analysis","volume":"7","author":"Lasa","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ecco-jcc\/jjz195","article-title":"Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice","volume":"14","author":"Gisbert","year":"2020","journal-title":"J. Crohn\u2019s Colitis"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/5\/1154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:30:12Z","timestamp":1760031012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/5\/1154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":127,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["biomedicines13051154"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13051154","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]}}}